Curriculum Vitae

Panagiotis ZOUMPOULAKIS
Researcher D
Institute of Biology, Medicinal Chemistry and Biotechnology
Division of Organic & Medicinal Chemistry (OMC)

FULL CV

Τηλ: +30 210 72 73 831 (Office)
       +30 210 72 73 869 (Laboratory)
Fax: +30 210 72 73 872
E-mail: pzoump

Academic Status:
2007 Masters of Business Administration (Executive MBA), Athens University of Economics and Business.
2004 PhD in Chemistry, Department of Chemistry, University of Patras.
1999 Diploma in Chemistry, Department of Chemistry, University of Patras.

Previous Positions:
31/10/2006-30/6/2010: Research Associate, Department of Food Technology, Technological Educational Institute of Athens
1/12/2004-30/11/06: Postdoctoral researcher, Institute of Organic and Pharmaceutical Chemistry, National Hellenic Research Foundation

• Structure/Ligand based drug design using Nuclear Magnetic Resonance Spectroscopy (NMR) and Molecular Modeling.
• Identification/tracing of functional compounds in food and beverages using NMR techniques.
• NMR based metabolomic studies in the field of  food and beverages

Publications:
26 publications in peer-reviewed multi-disciplinary scientific journals
6 Book Chapters in Collective volumes
10 publications in Greek scientific journals
17 publications in peer-reviewed conference proceedings
45 abstracts in conference proceedings
2 books and educational handouts

Workshops
Organization of Molecular Modeling workshops

• “2ο Workshop on Drug Design” Training of graduate and undergraduate students on rational drug design through Molecular Modeling, NMR and X-ray techniques. National Hellenic Research Foundation. Athens 2008.
• “1st Hellenic Workshop on Molecular Modeling and In Silico Docking applications in Drug Design” under the 14th Hellenic Symposium of Medicinal Chemistry, Thessaloniki, Greece, April 2010

Prizes and Awards
1. COST STSM grant  «In silico approaches for the design of novel TryS inhibitors with potential antileishmanial activity, Siena, Italy. May 2009
2. Scholarship from the State Scholarships Foundation of Greece for Post Doctoral research. October 05
3. ESF/EMBO scholarship for «Biomolecular NMR » Sweeden. August 05
4. Erasmus/Socrates Scholarship, University of Greenwich, London, UK. 1998

Selected Publications in International Peer-Reviewed Scientific Journals

1. Design and Synthesis of Novel Antihypertensive Drugs. P. Moutevelis-Minakakis, M. Gianni, H. Stougiannou, P. Zoumpoulakis, A. Zoga, A.D. Vlahakos, T. Mavromoustakos. Bioorg. Med. Chem. Lett. 13, (2003), 1737.                           
2. Losartan’s molecular basis of interaction with membranes and AT1 receptor. P. Zoumpoulakis, I. Daliani, M. Zervou, , I. Kyrikou, G. Lamprinidis, E. Mikros, T. Mavromoustakos. Chemistry and Physics of Lipids. 125, (2003), 13.
3. Efforts to Understand the Molecular Basis of Hypertension Through Drug:Membrane Interactions. T. Mavromoustakos, P. Zoumpoulakis, I. Kyrikou, A. Zoga, E. Siapi, M. Zervou, I. Daliani, D. Dimitriou, A. Pitsas, C. Kamoutsis, P. Laggner. Curr Top Med Chem.. 4, (2004), 445.
4. Synthesis, binding studies, and in vivo biological evaluation of novel non-peptide antihypertensive analogues. T. Mavromoustakos, P. Moutevelis-Minakakis, C.G. Kokotos, P. Kontogianni, A. Politi, P. Zoumpoulakis, J. Findlay, A. Cox, A. Balmforth, A. Zoga, E. Iliodromitis. Bioorg. Med. Chem., 14, (2006), 4353-4360.
5. Sulfonamide-1,2,4-triazole derivatives as antifungal and antibacterial agents.Synthesis, Biological evaluation, Lipophilicity and Conformational Studies. Iraj Rahabi Ezabadi, Charalabos Camoutsis, Panagiotis Zoumpoulakis, Athina Geronikaki, Marina Socovic, Jasmina Clamocilija and Ana Ciric. Bioorg. Med. Chem.,16, (2008), 1150-1161.
6. Antihypertensive Drug Valsartan in solution and at the AT1 Receptor: Conformational Analysis, Dynamic NMR Spectroscopy, in silico Docking and Molecular Dynamics Simulations. Constantinos Potamitis, Maria Zervou, Vassilis Katsiaras, Panagiotis Zoumpoulakis, Serdar Durdagi, Manthos G. Papadopoulos, Joseph M. Hayes,  Simona Golic Grdadolnik, Ioanna Kyrikou, Dimitris Argyropoulos,  Georgia Vatougia, Thomas Mavromoustakos, J. Chem. Inf. Model., 49 (3),(2009), 726-739.  
7. A computational study on cannabinoid receptors and potent bioactive cannabinoid ligands: homology modeling, docking, de novo drug design and molecular dynamics analysis, Serdar Durdagi, Manthos Papadopoulos, Panagiotis Zoumpoulakis, Catherine Koukoulitsa, Thomas Mavromoustakos, Molecular Diversity, 14, (2010), 257-276.
8. Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs, Kouatli Omar, Athina Geronikaki, Panagiotis Zoumpoulakis, Charalabos Camoutsis, Marina Sokovic, Ana Ciric, Jasmina Clamoclija, Bioorg. Med. Chem. 18, (2010), 426-432.
9.  Hypertension study in anaesthetized rabbits: protocol proposal for AT1 antagonists screening, Aggeliki P Politi, Maria V Zervou, Helen Triantafyllidi, Panagiotis G Zoumpoulakis, Thomas M Mavromoustakos, Anastasia A Zoga, Panagiota Moutevelis-Minakakis, George Kokotos,  Efstathios K Iliodromitis  and Dimitris Th Kremastinos,  JRAAS, 11(2), (2010), 103-10.
10. Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological Evaluation and Conformational Analysis Studies, P. Zoumpoulakis, Ch. Camoutsis, G. Pairas, M. Sokovic, J. Glamoclija, C. Potamitis, A. Pitsas, Bioorg. Med. Chem. doi:10.1016/j.bmc.2011.12.031 (2011).